GE Stock Forecast: General Electric Co gains momentum on a major analyst upgrade
Premium|Take advantage of 60% OFF on your first month.
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
You have reached your limit of 5 free articles for this month.
BLACK FRIDAY SALE! 60% OFF!
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
CLAIM OFFER- NYSE:GE added 4.66% on Tuesday alongside a broader market rally that saw the Dow’s best day in three months.
- A Bank of America analyst upgraded General Electric on some serious 2021 tailwinds.
- GE Healthcare won the award for the 2020 Global Company of the Year.
NYSE:GE has continued to claw its way back to relevance in 2021 after years of bleeding through its cash reserves. On Tuesday, General Electric gained 4.66% to close the trading session at $11.24 as the broader markets rebounded after a week of uncertainty from the r/WallStreetBets standoff. With the surge on Tuesday, GE is once again trading over its 50-day moving average and is now within reach of eclipsing its 52-week high price of $13.26, which the stock has not seen since before the outbreak of the COVID-19 pandemic.
On Monday, General Electric received a nice upgrade from an analyst at Bank of America, which raised his price target for the iconic American company to $14. The analyst, Andrew Orbin, cited significant tailwinds for 2021 which include an emphasis on renewable energies, a rebound of the commercial aviation industry, as well as strong guidance for between $2.5 billion and $4.5 billion in free cash flow. The $14 price target from Orbin represents a 25% premium on the closing price from Tuesday.
GE stock price forecast
General Electric’s healthcare division received a well-deserved honour recently as it was named the 2020 Global Company of the Year. The award is specifically for GE’s global healthcare command centers that support regional med-tech solutions, particularly during the recent COVID-19 pandemic. While General Electric is not usually noted or its healthcare branch, it should be good news to shareholders that the company’s other divisions are doing well at a time where the aviation department is slumping.
- NYSE:GE added 4.66% on Tuesday alongside a broader market rally that saw the Dow’s best day in three months.
- A Bank of America analyst upgraded General Electric on some serious 2021 tailwinds.
- GE Healthcare won the award for the 2020 Global Company of the Year.
NYSE:GE has continued to claw its way back to relevance in 2021 after years of bleeding through its cash reserves. On Tuesday, General Electric gained 4.66% to close the trading session at $11.24 as the broader markets rebounded after a week of uncertainty from the r/WallStreetBets standoff. With the surge on Tuesday, GE is once again trading over its 50-day moving average and is now within reach of eclipsing its 52-week high price of $13.26, which the stock has not seen since before the outbreak of the COVID-19 pandemic.
On Monday, General Electric received a nice upgrade from an analyst at Bank of America, which raised his price target for the iconic American company to $14. The analyst, Andrew Orbin, cited significant tailwinds for 2021 which include an emphasis on renewable energies, a rebound of the commercial aviation industry, as well as strong guidance for between $2.5 billion and $4.5 billion in free cash flow. The $14 price target from Orbin represents a 25% premium on the closing price from Tuesday.
GE stock price forecast
General Electric’s healthcare division received a well-deserved honour recently as it was named the 2020 Global Company of the Year. The award is specifically for GE’s global healthcare command centers that support regional med-tech solutions, particularly during the recent COVID-19 pandemic. While General Electric is not usually noted or its healthcare branch, it should be good news to shareholders that the company’s other divisions are doing well at a time where the aviation department is slumping.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.